Marc Bilodeau

6.0k total citations
103 papers, 3.8k citations indexed

About

Marc Bilodeau is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Marc Bilodeau has authored 103 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Hepatology, 50 papers in Epidemiology and 27 papers in Surgery. Recurrent topics in Marc Bilodeau's work include Liver Disease Diagnosis and Treatment (40 papers), Liver Disease and Transplantation (24 papers) and Hepatitis C virus research (19 papers). Marc Bilodeau is often cited by papers focused on Liver Disease Diagnosis and Treatment (40 papers), Liver Disease and Transplantation (24 papers) and Hepatitis C virus research (19 papers). Marc Bilodeau collaborates with scholars based in Canada, United States and France. Marc Bilodeau's co-authors include Valérie‐Ann Raymond, Al Slivinski, Jean‐Pierre Villeneuve, Denise Glaise, Christiane Guguen‐Guillouzo, Pascal Loyer, Pascal Lapierre, Sandrine Cariou, Isabelle Pache and Georges Baffet and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Marc Bilodeau

101 papers receiving 3.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marc Bilodeau Canada 32 1.8k 1.5k 798 758 368 103 3.8k
Michael Allison United Kingdom 36 2.0k 1.1× 3.2k 2.1× 1.2k 1.5× 872 1.2× 200 0.5× 108 6.4k
Roger Williams United Kingdom 52 3.5k 1.9× 2.8k 1.8× 2.4k 3.0× 1.2k 1.6× 618 1.7× 259 8.8k
Bettina Borisch Switzerland 30 508 0.3× 801 0.5× 247 0.3× 577 0.8× 728 2.0× 99 3.4k
Shingo Ishiguro Japan 34 540 0.3× 545 0.4× 3.1k 3.8× 1.0k 1.4× 1.7k 4.7× 169 7.8k
Christopher Bellamy United Kingdom 31 509 0.3× 571 0.4× 709 0.9× 791 1.0× 1.1k 3.0× 96 3.4k
Alberto Zambelli Italy 33 761 0.4× 823 0.5× 932 1.2× 1.2k 1.6× 1.6k 4.3× 172 4.2k
Mark Lynch United States 30 1.5k 0.8× 684 0.4× 546 0.7× 3.5k 4.6× 2.6k 7.0× 90 7.7k
Chiun Hsu Taiwan 44 2.6k 1.4× 1.5k 1.0× 907 1.1× 1.9k 2.5× 3.2k 8.7× 226 7.4k
Zhengwen Liu China 29 481 0.3× 758 0.5× 290 0.4× 575 0.8× 686 1.9× 117 2.8k
Stephen P. Dunn United States 30 490 0.3× 247 0.2× 819 1.0× 711 0.9× 297 0.8× 179 3.0k

Countries citing papers authored by Marc Bilodeau

Since Specialization
Citations

This map shows the geographic impact of Marc Bilodeau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Bilodeau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Bilodeau more than expected).

Fields of papers citing papers by Marc Bilodeau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc Bilodeau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Bilodeau. The network helps show where Marc Bilodeau may publish in the future.

Co-authorship network of co-authors of Marc Bilodeau

This figure shows the co-authorship network connecting the top 25 collaborators of Marc Bilodeau. A scholar is included among the top collaborators of Marc Bilodeau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc Bilodeau. Marc Bilodeau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bilodeau, Marc, et al.. (2024). Integration of Non-invasive Screening for Cystic Fibrosis Related Liver Disease in the Regular Follow-Up for Cystic Fibrosis. Digestive Diseases and Sciences. 70(2). 526–532. 1 indexed citations
2.
Bilodeau, Laurent, Catherine Huët, Assia Belblidia, et al.. (2023). IL-6 Trans-Signaling Is Increased in Diabetes, Impacted by Glucolipotoxicity, and Associated With Liver Stiffness and Fibrosis in Fatty Liver Disease. Diabetes. 72(12). 1820–1834. 14 indexed citations
3.
Raymond, Valérie‐Ann, et al.. (2023). Metabolomics-Guided Identification of a Distinctive Hepatocellular Carcinoma Signature. Cancers. 15(12). 3232–3232. 4 indexed citations
4.
Molina, Manuel Flores, Geneviève Soucy, Vincent Quoc‐Huy Trinh, et al.. (2022). Sex-Dependent Hepatoprotective Role of IL-22 Receptor Signaling in Non-Alcoholic Fatty Liver Disease-Related Fibrosis. Cellular and Molecular Gastroenterology and Hepatology. 14(6). 1269–1294. 18 indexed citations
5.
Chakravarti, Arpita, Guillaume Butler‐Laporte, François Martin Carrier, et al.. (2021). Targeted caspofungin prophylaxis for invasive aspergillosis in high‐risk liver transplant recipients, a single‐center experience. Transplant Infectious Disease. 23(4). e13568–e13568. 4 indexed citations
6.
Luo, Chi, Jiaxin Liang, Kfir Sharabi, et al.. (2020). Obesity/Type 2 Diabetes-Associated Liver Tumors Are Sensitive to Cyclin D1 Deficiency. Cancer Research. 80(16). 3215–3221. 16 indexed citations
7.
Hercun, Julian, Fernando Álvarez, Catherine Vincent, & Marc Bilodeau. (2019). Cystic fibrosis liver disease: A condition in need of structured transition and continuity of care. PubMed. 2(3). 71–83. 3 indexed citations
8.
Massicotte, Luc, François Martin Carrier, Pierre I. Karakiewicz, et al.. (2019). Impact of MELD Score–Based Organ Allocation on Mortality, Bleeding, and Transfusion in Liver Transplantation: A Before-and-After Observational Cohort Study. Journal of Cardiothoracic and Vascular Anesthesia. 33(10). 2719–2725. 11 indexed citations
9.
Carrier, François Martin, Michaël Chassé, Han Ting Wang, et al.. (2019). Restrictive fluid management strategies and outcomes in liver transplantation: a systematic review. Canadian Journal of Anesthesia/Journal canadien d anesthésie. 67(1). 109–127. 31 indexed citations
10.
Chan, Tom S., Shamir Cassim, Valérie‐Ann Raymond, et al.. (2018). Upregulation of Krebs cycle and anaerobic glycolysis activity early after onset of liver ischemia. PLoS ONE. 13(6). e0199177–e0199177. 30 indexed citations
11.
Hart, Kevin M., Thomas Fabre, Joshua Sciurba, et al.. (2017). Type 2 immunity is protective in metabolic disease but exacerbates NAFLD collaboratively with TGF-β. Science Translational Medicine. 9(396). 108 indexed citations
12.
Bhat, Mamatha, Peter Ghali, Benoît Dupont, et al.. (2016). Proposal of a novel MELD exception point system for hepatocellular carcinoma based on tumor characteristics and dynamics. Journal of Hepatology. 66(2). 374–381. 16 indexed citations
13.
Raymond, Valérie‐Ann, et al.. (2011). Liver Fibrosis Protects Mice From Acute Hepatocellular Injury. Gastroenterology. 142(1). 130–139.e4. 39 indexed citations
14.
Marleau, Denis, et al.. (2010). Identification of new donor variables associated with graft survival in a single-center liver transplant cohort. Liver Transplantation. 16(12). 1393–1399. 10 indexed citations
15.
Bilodeau, Marc & Richard Steinberg. (2006). Donative nonprofit organizations. RePEc: Research Papers in Economics. 1. 1271–1333. 5 indexed citations
16.
Zwingmann, Claudia & Marc Bilodeau. (2006). Metabolic insights into the hepatoprotective role of N-acetylcysteine in mouse liver. Hepatology. 43(3). 454–463. 70 indexed citations
17.
Pache, Isabelle & Marc Bilodeau. (2005). Severe haemorrhage following abdominal paracentesis for ascites in patients with liver disease. Alimentary Pharmacology & Therapeutics. 21(5). 525–529. 121 indexed citations
18.
Pomier–Layrargues, Gilles, J P Villeneuve, Marc Deschênes, et al.. (2001). Transjugular intrahepatic portosystemic shunt (TIPS) versus endoscopic variceal ligation in the prevention of variceal rebleeding in patients with cirrhosis: a randomised trial. Gut. 48(3). 390–396. 102 indexed citations
19.
Bilodeau, Marc, Hélène Talarmin, Gennady P. Ilyin, et al.. (1999). Skp2 induction and phosphorylation is associated with the late G1 phase of proliferating rat hepatocytes. FEBS Letters. 452(3). 247–253. 19 indexed citations
20.
Villeneuve, Jean‐Pierre, Marc Bilodeau, Raymond Lepage, Jean Côté, & Michel Lefebvre. (1996). Variability in hepatic iron concentration measurement from needle-biopsy specimens. Journal of Hepatology. 25(2). 172–177. 172 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael Allison Breakdown of academic impact, for papers by Roger Williams Breakdown of academic impact, for papers by Bettina Borisch Breakdown of academic impact, for papers by Shingo Ishiguro Breakdown of academic impact, for papers by Christopher Bellamy Breakdown of academic impact, for papers by Alberto Zambelli Breakdown of academic impact, for papers by Mark Lynch Breakdown of academic impact, for papers by Chiun Hsu Breakdown of academic impact, for papers by Zhengwen Liu Breakdown of academic impact, for papers by Stephen P. Dunn
Rankless by CCL
2026